Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
4.230
+0.330 (8.46%)
At close: Mar 9, 2026, 4:00 PM EDT
4.210
-0.020 (-0.47%)
After-hours: Mar 9, 2026, 4:57 PM EDT
Incannex Healthcare Employees
Incannex Healthcare had 12 employees as of June 30, 2025. The number of employees increased by 3 or 33.33% compared to the previous year.
Employees
12
Change (1Y)
3
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$4,041,667
Market Cap
50.52M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 12 | 3 | 33.33% |
| Jun 30, 2024 | 9 | 6 | 200.00% |
| Jun 30, 2021 | 3 | 1 | 50.00% |
| Jun 30, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 320 |
| Zhengye Biotechnology Holding | 277 |
| Rockwell Medical | 244 |
| Cumberland Pharmaceuticals | 91 |
| Aytu BioPharma | 83 |
| Assertio Holdings | 58 |
| BioXcel Therapeutics | 37 |
| SCYNEXIS | 28 |
IXHL News
- 12 days ago - Incannex Announces Reverse Stock Split - GlobeNewsWire
- 18 days ago - Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2026 - Newsfile Corp
- 5 weeks ago - Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board - GlobeNewsWire
- 6 weeks ago - Incannex Healthcare Announces Formation of Clinical Advisory Board for PSX-001 Program - GlobeNewsWire
- 7 weeks ago - Incannex Healthcare Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards - GlobeNewsWire
- 7 weeks ago - Incannex Healthcare Delivers Transformational 2025 Progress and Outlines Well-Funded Outlook for 2026 - GlobeNewsWire
- 3 months ago - Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA) - GlobeNewsWire
- 3 months ago - Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2026 - Newsfile Corp